Rationale, Definition, and History of Transarterial Chemoembolization
, 2023 Transarterial chemoembolization (TACE) is a minimally invasive technique used for the treatment of liver’s malignancies, mostly hepatocellular carcinoma (HCC). TACE allows administration of chemotherapy, carried in a mixture with Lipiodol (conventional TACE, C-TACE), or by drug-eluting beads (drug-eluting microsphere, DEM-TACE) [1], directly ...
Rocco, Bianca +4 more
openaire +2 more sources
Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma [PDF]
Diagnostic and Interventional Radiology, 2018 We aimed to compare the clinical effectiveness of combination therapy of transarterial chemoembolization (TACE) and microwave ablation (MWA) with TACE monotherapy in BCLC stage B HCC patients with tumor size ≤7 cm and tumor number ≤5.We retrospectively reviewed 150 BCLC stage B HCC patients who had received TACE monotherapy or TACE-MWA combination ...
Rusi Zhang +5 more
openaire +5 more sources
Clinics, 2015 OBJECTIVE: Transarterial chemoembolization is the treatment of choice for intermediate-stage hepatocellular carcinoma. However, there are no clear data supporting transarterial chemoembolization vs .
Lucas Moretti Monsignore +6 more
doaj +2 more sources
Balloon-Occluded Transarterial Chemoembolization for Hepatocellular Carcinoma: Technical Rationale, Current Evidence, and Future Directions [PDF]
Journal of Hepatocellular CarcinomaXiaoli Jia, Yuanyi Chen, Xiaomeng Cui, Yan Tian, Dandan Feng, Wenjun WangDepartment of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of ChinaCorrespondence: Wenjun Wang, Department of ...
Jia X +5 more
doaj +2 more sources
Hepatic Medicine: Evidence and Research, 2016 In hepatocellular carcinoma patients with large or multinodal tumors, where curative treatment options are not feasible, transarterial therapies play a major role. Transarterial chemoembolization (TACE) with drug-eluting beads (DEB-TACE) is a promising new approach due to higher intratumoral and lower systemic concentration of the chemotherapeutic ...
Baur, Johannes +5 more
openaire +6 more sources
Multiple acute complications of transarterial chemoembolization of liver metastases
Сучасні медичні технологіїThe aim of the work: to describe a clinical case of treatment of multiple acute complications after transarterial chemoembolization of liver metastases in a patient with pancreatic cancer. Materials and methods.
R. N. Abu Shamsia, Yu. M. Zakharash
doaj +2 more sources
Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival [PDF]
Canadian Journal of Gastroenterology, 2011 BACKGROUND: Transarterial chemoembolization (TACE) is the mainstay of management for patients with hepatocellular carcinoma who are not suitable for curative treatments.
Summit Sawhney +6 more
doaj +2 more sources
Efficacy of Hepatic Arterial Infusion Chemotherapy and Radiofrequency Ablation against Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization and Vascular Variation: A Case Study [PDF]
Kosin Medical Journal, 2021 Transarterial chemoembolization is often the first-line treatment for multiple hepatocellular carcinomas. However, hepatic arterial infusion chemotherapy is a treatment option for hepatocellular carcinoma refractory to multiple sessions of transarterial ...
Sang Yi Moon +2 more
doaj +1 more source
Efficiency of Transarterial Chemoembolization with Drug-Eluting Microspheres in the Treatment of Metastatic and Primary Liver Tumors [PDF]
Клиническая практика, 2023 Background: Transarterial chemoembolization (TACE) is coming into use in the treatment of liver tumors, with drug-eluting microspheres as one of the technique variations.
Elena A. Zvezdkina +6 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2022 Introduction: This retrospective study aimed to compare the efficacy and safety of transarterial chemoembolization plus lenvatinib and programmed death 1 (PD-1) inhibitors versus transarterial chemoembolization plus lenvatinib or sorafenib in patients ...
Shu Zhao MD +6 more
doaj +1 more source